EU willing to discuss proposal after US backs plan to waive COVID 19 vaccine patents

Moves to waive patents on COVID19 vaccines are gaining support. Those behind the proposal have said a waiver would boost global production and distribution, especially for poorer countries. The United States has thrown its weight behind the idea, and the European Union has said it is willing to discuss the proposal. Washington wants to pursue negotiations at the World Trade Organization, but drugmakers have argued it may not have the desired effect. The US had previously opposed the plan under the Trump administration. Subscribe to our channel here: Subscribe to our news service on Telegram: